Metabolism, protein and miRNA cross-talk in cell cycle and tumor progression
Metabolism, protein and miRNA cross-talk in cell cycle and tumor progression
批准号:
8464027
负责人:
DAVID M. HOCKENBERY
金额:
$34.33万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-05-01 至 2017-03-31
关键词:
AddressAffectAnabolismAntineoplastic AgentsArachidonic AcidsBioenergeticsCell CycleCell divisionCellsCholesterolCyclooxygenase InhibitorsDinoprostoneDiseaseDown-RegulationEnvironmentEnzymesEquilibriumFatty AcidsFibroblastsGene ProteinsHistone AcetylationInvestigationLeadLinkLipidsMYC geneMembraneMembrane MicrodomainsMetabolicMetabolic PathwayMetabolismMicroRNAsMitotic Cell CycleModelingNeoplasm MetastasisNutrientNutritionalOncogenesPalmitatesPathway interactionsPost-Translational Protein ProcessingProcessProliferatingProstaglandinsProteinsProteomicsRegulationRelative (related person)RelianceResearchResearch PersonnelRoleSaturated Fatty AcidsSignal TransductionSignal Transduction PathwaySourceSphingolipidsSystems BiologyToxic effectWorkaerobic glycolysisautocrinecancer cellcell growthdesaturaseindexinginhibitor/antagonistinsightlipid biosynthesislipid metabolismneoplasticneoplastic cellnovelnovel strategiesnutrient metabolismoncogene addictionoxidationpalmitoylationparacrineprogramsprotein metabolismprotein transportras Proteinsscaffoldstable isotopestem cell divisiontumortumor initiationtumor progressiontumorigenicuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): In neoplastic diseases, cellular reprogramming for continued proliferation, invasion and metastasis are essential for tumor initation and progression. An increased understanding of oncogene regulation of these processes is essential to successful therapy. Our research has focused on the essential role of altered bioenergetics and biosynthetic metabolism during cell cycle entry and tumor progression regulated by the oncogene c-Myc. We have recently developed a novel approach to trace metabolism of nutrients and their direct contribution to protein modifications and demonstrated regulation of histone acetylation by substrate supply during Myc-dependent cell cycle entry, a previously unappreciated connection between metabolism and post-translational modifications. Increased lipid biosynthesis in Myc-expressing cells may increase protein targeting to lipid rafts and our preliminary studies indicate increased raft-associated Ras protein during Myc- induced cell cycle entry. We also demonstrated increased prostaglandin E2 in media, and that cyclooxygenase inhibitors had selective anti-proliferative effects for Myc-expressing cells. Lastly, our stable isotope studies with a Myc inducible/regressible tumor model show that tumor initiation, progression and regression are associated with distinct alterations in metabolic flux, setting up a potential for endogenous lipotoxicity from saturated fatty acids after Myc inactivation. These results lead us to hypothesize that Myc directs metabolism in synergistic pathways to promote cell cycling and cell growth, and that loss of this integration is a cause of Myc oncogene addiction. We propose the following specific aims to address these hypotheses. Specific Aim 1. To analyze changes in lipid raft composition during Myc-dependent cell cycle entry. Specific Aim 2. To analyze the requirements for arachidonic acid metabolism during Myc-dependent cell cycle entry. Specific Aim 3. To determine the role of lipotoxicity in Myc oncogene addiction. Together these studies have the potential to change current paradigms regarding control of signaling networks, to provide insight into proteins and miRNAs that participate in alteration of cell fates during programming of cells from quiescent to proliferative and tumorigenic states, and to reveal mechanisms underlying oncogene addiction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Delineating the mechanisms and clinical utility of mtDNA mutagenesis in cancer
-
批准号:10603025
-
项目类别:
-
资助金额:$16.13万
-
财政年份:2017
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Metabolism, protein and miRNA cross-talk in cell cycle and tumor progression
-
批准号:8239473
-
项目类别:
-
资助金额:$36.52万
-
财政年份:2012
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Metabolism, protein and miRNA cross-talk in cell cycle and tumor progression
-
批准号:8624665
-
项目类别:
-
资助金额:$35.42万
-
财政年份:2012
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Metabolism, protein and miRNA cross-talk in cell cycle and tumor progression
-
批准号:8838733
-
项目类别:
-
资助金额:$36.52万
-
财政年份:2012
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Biomarker discovery for mitochondrial toxicants using metabolic footprinting
-
批准号:8336879
-
项目类别:
-
资助金额:$37.82万
-
财政年份:2011
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Biomarker discovery for mitochondrial toxicants using metabolic footprinting
-
批准号:8218308
-
项目类别:
-
资助金额:$39.56万
-
财政年份:2011
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Biomarker discovery for mitochondrial toxicants using metabolic footprinting
-
批准号:8691819
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2011
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Biomarker discovery for mitochondrial toxicants using metabolic footprinting
-
批准号:8484404
-
项目类别:
-
资助金额:$37.03万
-
财政年份:2011
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Metabolic alterations in advanced Breast Cancer and response to systemic therapy.
-
批准号:8181511
-
项目类别:
-
资助金额:$23.6万
-
财政年份:2010
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Mechanisms linking Nutrient supply & cell cycle/survival
-
批准号:7737152
-
项目类别:
-
资助金额:$25.12万
-
财政年份:2008
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Regulation of substrate-linked mitochondrial ROS generation
-
批准号:7030016
-
项目类别:
-
资助金额:$20.49万
-
财政年份:2006
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Regulation of substrate-linked mitochondrial ROS generation
-
批准号:7282707
-
项目类别:
-
资助金额:$14.96万
-
财政年份:2006
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Cell Metabolism and Myc induced growth, death, and neoplasia
-
批准号:7363649
-
项目类别:
-
资助金额:$28.72万
-
财政年份:2005
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Cell Metabolism & Myc induced growth, death, & neoplasia
-
批准号:6867657
-
项目类别:
-
资助金额:$32.07万
-
财政年份:2005
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Cell Metabolism & Myc induced growth death, & neoplasia
-
批准号:7017097
-
项目类别:
-
资助金额:$29.8万
-
财政年份:2005
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Cell Metabolism and Myc induced growth, death, and neoplasia
-
批准号:7216332
-
项目类别:
-
资助金额:$28.83万
-
财政年份:2005
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Cell Metabolism and Myc induced growth, death, and neoplasia
-
批准号:7578931
-
项目类别:
-
资助金额:$28.61万
-
财政年份:2005
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Small Molecule Inhibitors of BcI xL Survival Protein
-
批准号:6634048
-
项目类别:
-
资助金额:$43.73万
-
财政年份:2001
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Small Molecule Inhibitors of BcI xL Survival Protein
-
批准号:6753499
-
项目类别:
-
资助金额:$45.04万
-
财政年份:2001
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Small Molecule Inhibitors of BcI xL Survival Protein
-
批准号:6515083
-
项目类别:
-
资助金额:$42.45万
-
财政年份:2001
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
海外基金